Bosentan improves exercise capacity in adolescents and adults after Fontan operation: the TEMPO (Treatment With Endothelin Receptor Antagonist in Fontan Patients, a Randomized, Placebo-Controlled, Double-Blind Study Measuring Peak Oxygen Consumption) study.

Hebert, Anders; Mikkelsen, Ulla R; Thilen, Ulf; Idorn, Lars; Jensen, Annette S; Nagy, Edit; Hanseus, Katarina; Sørensen, Keld E; Søndergaard, Lars.
Circulation; 130(23): 2021-30, 2014 Dec 02.
Artigo em Inglês | MEDLINE | ID: mdl-25446057